IFNA1 and Abnormal renal physiology: Among the 54 patients who received IFN-α therapy, the main side effects included pyrexia (61.11%), muscle pain (24.07%), malaise (9.26%), anorexia (5.56%), hepatic dysfunction (3.70%) and renal dysfunction (1.85%).